The role of TNFRSF25:TNFSF15 in disease⋯ and health?

Advances in Experimental Medicine and Biology

Volumn 691, Issue , 2011, Pages 289-298

  Schreiber, Taylor H ^a   Wolf, Dietlinde ^a   Podack, Eckhard R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH RECEPTOR 3; INTERLEUKIN 12; INTERLEUKIN 18; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

ALLERGIC ASTHMA; ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNITY; CELLULAR DISTRIBUTION; CONFERENCE PAPER; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENTERITIS; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LIGAND BINDING; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; T LYMPHOCYTE; ANIMAL; CHEMISTRY; GENERAL ASPECTS OF DISEASE; HEALTH; METABOLISM; REVIEW;

ANIMALS; DISEASE; HEALTH; HUMANS; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 25; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

EID: 79954432140     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6612-4_30     Document Type: Conference Paper

References (42)

1. Al-Lamki RS, Wang J, Tolkovsky AM, Bradley JA, Griffin JL, Thiru S, Wang EC, Bolton E, Min W, Moore P et al (2008) TL1A both promotes and protects from renal inflammation and injury. J Am Soc Nephrol 19:953-960
2. Al-Shamkhani A, Mallett S, Brown MH, JamesW, Barclay AN (1997) Affinity and kinetics of the interaction between soluble trimeric OX40 ligand, a member of the tumor necrosis factor superfamily, and its receptor OX40 on activated T cells. J Biol Chem 272:5275-5282
3. Ashkenazi A, Dixit VM (1998) Death receptors: Signaling and modulation. Science (New York, NY) 281:1305-1308
4. Bamias G, Martin C 3rd, Marini M, Hoang S, Mishina M, Ross WG, Sachedina MA, Friel CM, Mize J, Bickston SJ et al (2003) Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J Immunol 171: 4868-4874
5. Bodmer JL, Burns K, Schneider P, Hofmann K, Steiner V, Thome M, Bornand T, Hahne M, Schroter M, Becker K et al (1997) TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 6:79-88
6. Borysenko CW, Furey WF, Blair HC (2005) Comparative modeling of TNFRSF25 (DR3) predicts receptor destabilization by a mutation linked to rheumatoid arthritis. Biochem Biophy Res Commun 328:794-799
7. Bull MJ, Williams AS, Mecklenburgh Z, Calder CJ, Twohig JP, Elford C, Evans BA, Rowley TF, Slebioda TJ, Taraban VY et al (2008) The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis. J Exp Med 205:2457-2464
8. Cassatella MA, Pereira-da-Silva G, Tinazzi I, Facchetti F, Scapini P, Calzetti F, Tamassia N, Wei P, Nardelli B, Roschke V et al (2007) Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis. J Immunol 178:7325-7333
9. Chinnaiyan AM, O'Rourke K, Yu GL, Lyons RH, Garg M, Duan DR, Xing L, Gentz R, Ni J, Dixit VM (1996) Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science (New York, NY) 274:990-992
10. Crowe PD, Van Arsdale TL, Walter BN, Ware CF, Hession C, Ehrenfels B, Browning JL, Din WS, Goodwin RG, Smith CA (1994) A lymphotoxin-beta-specific receptor. Science (New York, NY) 264:707-710
11. Fang L, Adkins B, Deyev V, Podack ER (2008) Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation. J Exp Med 205:1037-1048
12. Jin, T, Guo F, Kim S, Howard A, Zhang YZ (2007) X-ray crystal structure of TNF ligand family member TL1A at 2.1A. Biochem Biophy Res Commun 364:1-6
13. Kakuta Y, Kinouchi Y, Negoro K, Takahashi S, Shimosegawa T (2006) Association study of TNFSF15 polymorphisms in Japanese patients with inflammatory bowel disease. Gut 55:1527-1528
14. Kayamuro H, Yoshioka Y, Abe Y, Katayama K, Yoshida T, Yamashita K, Yoshikawa T, Hiroi T, Itoh N, Kawai Y et al (2009) TNF superfamily member, TL1A, is a potential mucosal vaccine adjuvant. Biochem Biophy Res Commun 384:296-300
15. Kitson J, Raven T, Jiang YP, Goeddel DV, Giles KM, Pun KT, Grinham CJ, Brown R, Farrow SN (1996) A death-domain-containing receptor that mediates apoptosis. Nature 384:372-375
16. Kleinschek MA, Owyang AM, Joyce-Shaikh B, Langrish CL, Chen Y, Gorman DM, Blumenschein WM, McClanahan T, Brombacher F, Hurst SD et al (2007) IL-25 regulates Th17 function in autoimmune inflammation. J Exp Med 204:161-170
17. Marsters SA, Sheridan JP, Donahue CJ, Pitti RM, Gray CL, Goddard AD, Bauer KD, Ashkenazi A (1996) Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B. Curr Biol 6:1669-1676
18. Meylan F, Davidson TS, Kahle E, Kinder M, Acharya K, Jankovic D, Bundoc V, Hodges M, Shevach EM, Keane-Myers A et al (2008) The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity 29:79-89
19. Micheau O, Tschopp J (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114:181-190
20. Migone TS, Zhang J, Luo X, Zhuang L, Chen C, Hu B, Hong JS, Perry JW, Chen SF, Zhou JX et al (2002) TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16:479-492
21. Mongkolsapaya J, Grimes JM, Chen N, Xu XN, Stuart DI, Jones EY, Screaton GR (1999) Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation. Nature Struct Biol 6:1048-1053
22. Noble JA, Valdes AM, Lane JA, Green AE, Erlich HA (2006) Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-alpha polymorphisms on type 1 diabetes susceptibility. Human Immunol 67:999-1004
23. Osawa K, Takami N, Shiozawa K, Hashiramoto A, Shiozawa S (2004) Death receptor 3 (DR3) gene duplication in a chromosome region 1p36.3: Gene duplication is more prevalent in rheumatoid arthritis. Genes and Immun 5:439-443
24. Papadakis KA, Prehn JL, Landers C, Han Q, Luo X, Cha SC, Wei P, Targan SR (2004) TL1A synergizes with IL-12 and IL-18 to enhance IFN-gamma production in human T cells and NK cells. J Immunol 172:7002-7007
25. Papadakis KA, Zhu D, Prehn JL, Landers C, Avanesyan A, Lafkas G, Targan SR (2005) Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes. J Immunol 174:4985-4990
26. Pappu BP, Borodovsky A, Zheng TS, Yang X,Wu P, Dong X,Weng S, Browning B, ScottML, Ma L et al (2008) TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J Exp Med 205:1049-1062
27. Prehn JL, Mehdizadeh S, Landers CJ, Luo X, Cha SC,Wei P, Targan SR (2004) Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation. Clin Immunol (Orlando, FL) 112:66-77
28. Prehn JL, Thomas LS, Landers CJ, Yu QT, Michelsen KS, Targan SR (2007) The T cell costimulator TL1A is induced by FcgammaR signaling in human monocytes and dendritic cells. J Immunol 178:4033-4038
29. Saruta M, Michelsen KS, Thomas LS, Yu QT, Landers CJ, Targan SR (2009) TLR8-mediated activation of human monocytes inhibits TL1A expression. Eur J Immunol 39:2195-2202
30. Screaton GR, Xu XN, Olsen AL, Cowper AE, Tan R, McMichael AJ, Bell JI (1997) LARD: A new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc Natl Acad Sci U S A 94:4615-4619
31. Su WB, Chang YH, Lin WW, Hsieh SL (2006) Differential regulation of interleukin-8 gene transcription by death receptor 3 (DR3) and type I TNF receptor (TNFRI). Exp Cell Res 312:266-277
32. Takami N, Osawa K, Miura Y, Komai K, Taniguchi M, Shiraishi M, Sato K, Iguchi T, Shiozawa K, Hashiramoto A, Shiozawa S (2006) Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells. Arthrit Rheumat 54: 779-787
33. Takedatsu H, Michelsen KS, Wei B, Landers CJ, Thomas LS, Dhall D, Braun J, Targan SR (2008) TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology 135:552-567
34. Tan KB, Harrop J, Reddy M, Young P, Terrett J, Emery J, Moore G, Truneh A (1997) Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene 204:35-46
35. Wallach D, Kovalenko A (2009) 12th international TNF conference: The good, the bad and the scientists. Cytokine Grow Factor Rev 20:259-269
36. Wang EC, Kitson J, Thern A, Williamson J, Farrow SN, Owen MJ (2001a) Genomic structure, expression, chromosome mapping of the mouse homologue for the WSL-1 (DR3, Apo3, TRAMP, LARD, TR3, TNFRSF12) gene. Immunogenetics 53:59-63
37. Wang EC, Thern A, Denzel A, Kitson J, Farrow SN, OwenMJ (2001b) DR3 regulates negative selection during thymocyte development. Mol Cell Biol 21:3451-3461
38. Warzocha K, Ribeiro P, Charlot C, Renard N, Coiffier B, Salles G (1998) A new death receptor 3 isoform: Expression in human lymphoid cell lines and non-Hodgkin's lymphomas. Biochem Biophy Res Commun 242:376-379
39. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM (2006) Th17: An effector CD4 T cell lineage with regulatory T cell ties. Immunity 24:677-688
40. Wen L, Zhuang L, Luo X, Wei P (2003) TL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells. J Biol Chem 278:39251-39258
41. Yamazaki K, McGovern D, Ragoussis J, Paolucci M, Butler H, Jewell D, Cardon L, Takazoe M, Tanaka T, Ichimori T et al (2005) Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Human Mol Genet 14:3499-3506
42. Zhang J, Wang X, Fahmi H, Wojcik S, Fikes J, Yu Y, Wu J, Luo H (2009) Role of TL1A in the pathogenesis of rheumatoid arthritis. J Immunol 183:5350-5357